Atıl Bişgin

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

Atıl Bişgin, Reginald M. Gorczynski · Diabetes Research and Clinical Practice · 2012 · 32 citations

Inflammation, Metabolic Syndrome, Diabetes Management +11

Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis

Atıl Bişgin, Ahter Dilşad Şanlioğlu, M. Ulker et al. · Lara D. Veeken · 2007 · 32 citations · Full text

In Vivo Gene Therapy, Immunology, Pathology +17

Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients

Gülen Gül Mert, Neslihan Özcan, Özlem Hergüner et al. · Acta Neurologica Belgica · 2019 · 18 citations

Long-term Follow-up, Genetic Features, Congenital Myasthenic Syndrome

Gender Identity and Assignment Recommendations in Disorders of Sex Development Patients: 20 Years’ Experience and Challenges

Fatih Gürbüz, Murat Alkan, Gonca Gül Çelik et al. · Journal of Clinical Research in Pediatric Endocrinology · 2020 · 14 citations · Full text

The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study

Rabia Miray Kışla Ekinci, Sibel Balcı, Atıl Bişgin et al. · Reumatologia/Rheumatology · 2020 · 12 citations · Full text